EMG
DCPH

ETF Managers Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

ETF Managers Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27,678
Closed -$373K – 838
2022
Q2 		$373K Buy
+27,678
New +$305K 0.01% 566

Other funds holding DCPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

ETF Managers Group's DCPH Position: Q3 2022 in Review

ETF Managers Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2022, closing a stake of 27,678 shares — an estimated $373K sold.

ETF Managers Group first reported a position in DCPH in Q2 2022 and held it in 1 quarter. The position peaked at $373K in Q2 2022. 150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

  • ETF Managers Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • ETF Managers Group sold 27,678 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $373K.
  • ETF Managers Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • ETF Managers Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $373K in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.